- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Mankind Pharma Limited — Important, 11-07-2026: Diversification/Disinvestment
11-07-2026 | 01:26 pm
11-07-2026 | 01:26 pm
Mankind Pharma's board approved divesting 100% stake in non-core subsidiary Broadway for ₹49 Cr. They also approved incorporating a Netherlands WOS to hold R&D investments in niche therapies, with planned investment up to Euro 5 Million.
No comments yet. Be the first to comment!